Prediction rule/guideline | n/Na | %test positive | % sensitivity (95% CI) | % specificity (95% CI) | Likelihood ratio (95% CI) | |
---|---|---|---|---|---|---|
positive | negative | |||||
Bleeker | 126/731 | 62.9% | 81.0 (73.0–87.4) | 40.8 (36.9–44.9) | 1.37 (1.23–1.52) | 0.47 (0.32–0.68) |
Thayyil | 162/1001 | 5.2% | 31.7 (24.7–39.4) | 74.4 (71.3–77.4) | 1.24 (0.96–1.60) | 0.92 (0.82–1.03) |
Lab Score | 126/731 | 68.3% | 70.6 (61.9–78.4) | 32.2 (28.5–36.1) | 1.04 (0.92–1.18) | 0.91 (0.68–1.22) |
Rotterdam fever model | ||||||
2.5% risk | 161/985 | 66.50% | 77.3 (70.1–83.5) | 35.6 (32.4–39.0) | 1.21 (1.10–1.32) | 0.64 (0.47–0.86) |
5% risk | 161/985 | 55.53% | 69.9 (62.3–76.9) | 47.3 (43.9–50.8) | 1.33 (1.18–1.50) | 0.64 (0.50–0.81) |
15% risk | 161/985 | 36.24% | 49.7 (41.8–57.6) | 66.4 (63.1–69.6) | 1.48 (1.23–1.78) | 0.76 (0.65–0.89) |
IMCI | 164/1005 | 30.8% | 36.7 (29.4–44.6) | 70.3 (67.1–73.4) | 1.22 (0.97–1.55) | 0.90 (0.79–1.02) |
iCCM | 164/1005 | 30.5% | 36.7 (29.4–44.6) | 70.7 (67.5–73.7) | 1.25 (1.00–1.57) | 0.89 (0.79–1.01) |
ALMANACH | 164/1005 | 44.3% | 63.3 (55.4–70.6) | 63.2 (59.8–66.4) | 1.72 (1.48–1.99) | 0.58 (0.47–0.71) |
NICE | 164/1005 | 76.0% | 83.7 (77.2–89.0) | 25.5 (22.6–28.6) | 1.12 (1.04–1.22) | 0.64 (0.44–0.92) |
AAEP | 164/1005 | 41.7% | 68.1 (60.4–75.1) | 63.5 (60.2–66.8) | 1.87 (1.63–2.14) | 0.50 (0.40–0.63) |